|
crofelemer |
|---|---|
| Trade Name | Mytesi |
| Orphan Indication | Short bowel syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2017-08-02 00:00:00 |
| Sponsor | Napo Pharmaceuticals, Inc.;201 Mission Street, Suite 2375;San Francisco, California, 94105 |
|
crofelemer |
|---|---|
| Trade Name | Mytesi |
| Orphan Indication | Short bowel syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2017-08-02 00:00:00 |
| Sponsor | Napo Pharmaceuticals, Inc.;201 Mission Street, Suite 2375;San Francisco, California, 94105 |